Overview
Koji Haratani is an Oncologist in Boston, Massachusetts. Dr. Haratani is highly rated in 4 conditions, according to our data. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Lung Cancer, and Febrile Neutropenia.
His clinical research consists of co-authoring 67 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Massachusetts General Physicians Organization Inc
Jeremy Abramson is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Abramson is highly rated in 28 conditions, according to our data. His top areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, Classical Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Abramson is currently accepting new patients.
The General Hospital Corporation
Edwin Choy is an Oncologist and a Hematologist Oncology provider in Boston, Massachusetts. Dr. Choy is highly rated in 34 conditions, according to our data. His top areas of expertise are Adult Soft Tissue Sarcoma, Liposarcoma, Osteosarcoma, and Synovial Sarcoma. Dr. Choy is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Caron Jacobson is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Jacobson is highly rated in 25 conditions, according to our data. Her top areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, Follicular Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Jacobson is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- EGFR Positive Lung CancerDr. Haratani isDistinguished. Learn about EGFR Positive Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Haratani isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- Febrile NeutropeniaDr. Haratani isAdvanced. Learn about Febrile Neutropenia.
- Lung CancerDr. Haratani isAdvanced. Learn about Lung Cancer.
- Experienced
- Lung AdenocarcinomaDr. Haratani isExperienced. Learn about Lung Adenocarcinoma.
- Small Cell Lung Cancer (SCLC)Dr. Haratani isExperienced. Learn about Small Cell Lung Cancer (SCLC).